If you didn't think the hold was BS, this from Dr.
Post# of 145345
The CD10 study continued to demonstrate the safety of leronlimab. Altogether, over 1,200 patients have now received the drug, including HIV+, Cancer, and Covid patients, without a discernible safety signal.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)